Joshua S Sulat

Biography

James Sulat has been a director since April 2014. Mr. Sulat served as the chief executive officer and chief financial officer of Maxygen, Inc. from 2009 to 2013, and as a member of its board of directors from 2003 to 2013. From 2005 to 2009, Mr. Sulat served as president and chief executive officer and then as chief financial officer of Memory Pharmaceuticals Corporation, as well as a member of its board of directors. Prior to these roles, Mr. Sulat was the chief financial officer in several different large and mid-sized public companies. Mr. Sulat serves as chairman of the board of directors for Momenta Pharmaceuticals, Inc., and serves on the board of directors of Arch Therapeutics, Inc., Diadexus, Inc., and Valneva SE. Mr. Sulat received a Bachelor of Science in Administrative Sciences from Yale University, and a Master of Business Administration and a Master of Science in Health Services Administration from Stanford University.

Research Interest

healthcare